https://www.healio.com/news/endocrinology/20220921/adults-with-type-2-diabetes-reach-hba1c-target-faster-with-tirzepatide-than-semaglutide
0
0
9/21/22 at 1:23pm
Organization
Healio
Authors
Adults with type 2 diabetes assigned tirzepatide achieved glycemic targets in a shorter time than those taking 1 mg semaglutide or titrated insulin degludec, according to an analysis of SURPASS-2 and SURPASS-3 data.
In findings presented at the European Asso…
Create an account
or login to join the discussion